These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35801797)

  • 1. Matched-pair analysis of survival in patients with poorly differentiated versus well and moderately differentiated hypopharyngeal squamous cell carcinoma.
    Xia X; Liang Y; Zhu Y; Zhu X; Diao W; Chen X
    Medicine (Baltimore); 2022 Jul; 101(27):e29880. PubMed ID: 35801797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
    Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
    World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
    BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of postoperative recurrence in hypopharyngeal squamous-cell carcinoma patients with nodal metastasis.
    Lin H; Wang T; Heng Y; Zhu X; Zhou L; Zhang M; Shi Y; Cao P; Tao L
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):803-811. PubMed ID: 32728810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma.
    Cai Z; Chen L; Chen S; Fang R; Chen X; Lei W
    Cell Commun Signal; 2023 Oct; 21(1):292. PubMed ID: 37853464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.
    Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y
    Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of neck dissection for 154 cN0/cN1 patients with squamous cell carcinoma of hypopharynx and prognostic analysis].
    Tao L; Zhou L; Wu HT; Zhang M; Li XM; Chen XL; Li C; Xie M; Cheng L; Zhang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):272-279. PubMed ID: 30991777
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study.
    Huang Q; Ye M; Li F; Lin L; Hu C
    BMC Cancer; 2022 Sep; 22(1):1019. PubMed ID: 36163022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoral robotic surgery in patients with stage III/IV hypopharyngeal squamous cell carcinoma: treatment outcome and prognostic factor.
    Park YM; Kim DH; Kang MS; Lim JY; Koh YW; Kim SH
    Acta Otolaryngol; 2019 Sep; 139(9):816-822. PubMed ID: 31268399
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic value of USP7 and p53 in advanced hypopharyngeal carcinoma.
    Sun J; Lin L; Zhang J; Hu C; Wang J
    Ann Diagn Pathol; 2021 Apr; 51():151695. PubMed ID: 33460997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
    Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Notsu A; Sato F; Kawakami T; Ogawa H; Onoe T; Mukaigawa T
    BMC Cancer; 2022 Oct; 22(1):1101. PubMed ID: 36303119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Survival Nomogram Containing Lymph Node Ratio for Hypopharyngeal Carcinoma Patients After Neck Dissection.
    Li F; Huang Q; Hsueh C; Huang H; Zhu Y; Gong H; Tao L; Zhou L; Zhang M
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1097-1106. PubMed ID: 36939525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
    Liang Z; Wu M; Wang P; Quan H; Zhao J
    PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
    Hu C; Tian S; Lin L; Zhang J; Ding H
    Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis.
    Abdeyrim A; He S; Zhang Y; Mamtali G; Asla A; Yusup M; Liu J
    J Otolaryngol Head Neck Surg; 2020 May; 49(1):31. PubMed ID: 32471483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resections.
    Song Y; Liu H; Gao L; Liu X; Ma L; Lu M; Gao Z
    J Craniofac Surg; 2015 Mar; 26(2):e137-40. PubMed ID: 25643330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological and functional outcomes of transoral laser surgery for hypopharyngeal carcinoma.
    Casanueva R; López F; García-Cabo P; Álvarez-Marcos C; Llorente JL; Rodrigo JP
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):829-837. PubMed ID: 36056169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen-to-lymphocyte Ratio Predicts the Outcomes of Hypopharyngeal Squamous Cell Carcinoma Treated With Definitive Radiotherapy.
    Sato K; Hatakeyama H; Okada H; Kawano M; Yoshida K; Oki Y; Kuwahara T; Niwa K; Isono Y; Oridate N
    In Vivo; 2023; 37(3):1281-1289. PubMed ID: 37103064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer.
    Mints M; Landin D; Näsman A; Mirzaie L; Ursu RG; Zupancic M; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
    Sci Rep; 2021 Jan; 11(1):1782. PubMed ID: 33469045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.